Posts by: BNS Staff

Cystic Fibrosis, News

In a summer dominated by news of Vertex Pharmaceuticals’ breakthrough cystic fibrosis combo therapy of Kalydeco with Lumacaftor proving to be effective in treating the underlying cause of the disease in ... Read more

August 8, 2014

Discovery of Aiolos Protein Reveals How Cancer Cells Spread in Lung Cancer

Lung Cancer, News

A new protein called Aiolos, which plays a major role in allowing cancer cells to spread in a wide range of cancer indications such as lung cancer, has been identified by ... Read more

May 22, 2014November 6, 2015

Non-Cystic Fibrosis Bronchiectasis Drug Pulmaquin Receives QIDP Designation From FDA

Bronchiectasis

Aradigm Corporation’s experimental therapy Pulmaquin, an inhaled antibiotic for the treatment of non-cystic fibrosis bronchiectasis, was recently given the Qualified Infectious Disease Product (QIDP) designation from the U.S. Food and Drug Administration (FDA). The ... Read more

May 22, 2014May 22, 2014

New Trial Will Test Oncoprex Lung Cancer Drug In Combination Therapy

Lung Cancer, News

A subset of lung cancer patients who have already undergone treatment with a popular drug may benefit from a combination therapy that include’s Genprex’s experimental therapy Oncoprex. The company recently announced ... Read more

May 21, 2014November 11, 2015

Drug To Treat Alpha-1 Antitrypsis Deficiency Associated With COPD, Panacinar Emphysema Fails Key Trial

COPD

Kamada Ltd, an Israel-based drug maker, announced that its experimental inhaled drug AAT for the treatment of alpha-1 antitrypsin deficiency recently failed to meet endpoints in a key trial. Kamada is planning to ... Read more

May 21, 2014November 11, 2015

Three Uniquely Different COPD Treatments Making A Difference In Patients’ Lives

COPD, News

Scientists have discovered three new treatments for Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of death in the U.S. Responsible for 130,000 deaths in America each year, COPD ... Read more

May 20, 2014November 11, 2015

Updated COPD Guidelines Reflect Continued Development of Treatment Best Practices

COPD

Governing health bodies around the world continue to revise and improve treatment best practices for chronic obstructive pulmonary disease (COPD) thanks to ongoing research and medical advancements. The results of a ... Read more

May 20, 2014November 5, 2015

Key Patent Acquisitions Give Aventis Pharma Innovative Screening Tool For Treating CF Patients

Cystic Fibrosis, News

Cystic fibrosis (CF), a disease caused by a mutation in the gene known as CFTR (Cystic Fibrosis Transmembrane Conductance Regulator), affects the secretion deposits on mucous membranes in the respiratory and digestive system. In ... Read more